3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Classical hematology
1
Conditions
Lymphoma, Follicular
1
Hemophilia A
1
Coagulation Protein Disorders
1
Blood Coagulation Disorders
1
Interventions
Rituximab
90
Cyclophosphamide
30
Lenalidomide
28
Bendamustine Hydrochloride
24
Prednisone
20
Vincristine
19
obinutuzumab
17
Doxorubicin
16
fludarabine
14
ibrutinib
13
tazemetostat
9
idelalisib
9
Deoxycholic Acid
9
parsaclisib
8
Prednisolone
8
zanubrutinib
7
venetoclax
7
tofacitinib
7
tisagenlecleucel
5
pembrolizumab
5
ofatumumab
5
ibritumomab tiuxetan
5
duvelisib
5
Gemcitabine
5
Bortezomib
5
durvalumab
4
aflibercept
4
R-CHOP protocol
4
Methylprednisolone
4
Methotrexate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Lymphoma, Follicular
×
BIVV001
×
Clear all
NCT06716814
2026-04-20
LIBERTY
Swedish Orphan Biovitrum
Phase 3
Recruiting
104 enrolled